Frozen Shoulder Clinical Trial
Official title:
A Central Nervous System Focused Treatment Approach for People With Frozen Shoulder: Protocol for a Randomised Clinical Trial
Verified date | July 2022 |
Source | University of Valencia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to compare the effectiveness of a CNS-directed treatment program versus a standard medical and physiotherapy care program on outcomes in participants with FS.Participants will be randomized to receive either a 10 weeks CNS-focused treatment program or standard medical and physiotherapy care.To evaluate the results of the interventions, the subjects will be assessed at the beginning, at the end of the treatment program (week 10) and at 3 and 6 months of follow-up.
Status | Completed |
Enrollment | 34 |
Est. completion date | February 18, 2021 |
Est. primary completion date | February 18, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Primary or idiopathic Frozen Shoulder (FS), defined as FS not associated with a systemic condition or history of injury - greater than 50% reduction in passive external rotation when compared to the uninvolved shoulder or less than 30° of external rotation - range of motion loss of greater than 25% in at least two movement planes in comparison to the uninvolved shoulder - pain and restricted movement present for at least one month reaching a plateau or worsening - normal shoulder X-rays (with the exception of osteopenia of the humeral head and calcific tendinosis) Exclusion Criteria: - Locked dislocations, arthritis, fractures or avascular necrosis on radiographs - surgery in the upper quadrant region <12 months prior to the study - skin or medical conditions that prevents from receiving tactile stimuli on the shoulder - neurological or motor disorders including a diagnosis of dyslexia or difficulty performing a rapid naming task - visually and mental health conditions that precludes successful participation. |
Country | Name | City | State |
---|---|---|---|
Spain | University of Valencia | Valencia |
Lead Sponsor | Collaborator |
---|---|
University of Valencia |
Spain,
Desroches G, Desmeules F, Gagnon DH. Characterization of humeral head displacements during dynamic glenohumeral neuromuscular control exercises using quantitative ultrasound imaging: A feasibility study. Musculoskelet Sci Pract. 2017 Jun;29:150-154. doi: — View Citation
Louw A, Diener I, Butler DS, Puentedura EJ. The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil. 2011 Dec;92(12):2041-56. doi: 10.1016/j.apmr.2011.07.198. Review. — View Citation
Louw A, Puentedura EJ, Reese D, Parker P, Miller T, Mintken PE. Immediate Effects of Mirror Therapy in Patients With Shoulder Pain and Decreased Range of Motion. Arch Phys Med Rehabil. 2017 Oct;98(10):1941-1947. doi: 10.1016/j.apmr.2017.03.031. Epub 2017 — View Citation
Moseley G, Butler D, Beames T, Giles T. The graded motor imagery handbook. Adelaide: Noigroup Publishing; 2012.
Moseley GL. Do training diaries affect and reflect adherence to home programs? Arthritis Rheum. 2006 Aug 15;55(4):662-4. — View Citation
Mottram SL, Woledge RC, Morrissey D. Motion analysis study of a scapular orientation exercise and subjects' ability to learn the exercise. Man Ther. 2009 Feb;14(1):13-8. Epub 2007 Oct 1. — View Citation
Wand BM, O'Connell NE, Di Pietro F, Bulsara M. Managing chronic nonspecific low back pain with a sensorimotor retraining approach: exploratory multiple-baseline study of 3 participants. Phys Ther. 2011 Apr;91(4):535-46. doi: 10.2522/ptj.20100150. Epub 201 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | shoulder pain-related disability questionnaire (SPADI) | The SPADI is a 13-items shoulder function index assessing pain and disability related to shoulder dysfunction. Each item is scored by a numeric rate scale ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help). The total score ranges from 0 to 100 points where a higher score indicates greater disability. | Baseline | |
Primary | shoulder pain-related disability questionnaire (SPADI) | The SPADI is a 13-items shoulder function index assessing pain and disability related to shoulder dysfunction. Each item is scored by a numeric rate scale ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help). The total score ranges from 0 to 100 points where a higher score indicates greater disability. | Change from baseline SPADI at 10 weeks | |
Primary | shoulder pain-related disability questionnaire (SPADI) | The SPADI is a 13-items shoulder function index assessing pain and disability related to shoulder dysfunction. Each item is scored by a numeric rate scale ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help). The total score ranges from 0 to 100 points where a higher score indicates greater disability. | Change from baseline SPADI at 3 months | |
Primary | shoulder pain-related disability questionnaire (SPADI) | The SPADI is a 13-items shoulder function index assessing pain and disability related to shoulder dysfunction. Each item is scored by a numeric rate scale ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help). The total score ranges from 0 to 100 points where a higher score indicates greater disability. | Change from baseline SPADI at 6 months | |
Secondary | Numeric Pain Rating Scale | a valid and reliable measure of shoulder pain. Participants will be presented with numerical rating scales anchored with 0 ("no pain") and 10 ("pain as bad as you can imagine"). | Baseline | |
Secondary | Numeric Pain Rating Scale | a valid and reliable measure of shoulder pain. Participants will be presented with numerical rating scales anchored with 0 ("no pain") and 10 ("pain as bad as you can imagine"). | Change from baseline Numeric Rating Pain Scale at 10 weeks | |
Secondary | Numeric Pain Rating Scale | a valid and reliable measure of shoulder pain. Participants will be presented with numerical rating scales anchored with 0 ("no pain") and 10 ("pain as bad as you can imagine"). | Change from baseline Numeric Rating Pain Scale at 3 months | |
Secondary | Numeric Pain Rating Scale | a valid and reliable measure of shoulder pain. Participants will be presented with numerical rating scales anchored with 0 ("no pain") and 10 ("pain as bad as you can imagine"). | Change from baseline Numeric Rating Pain Scale at 6 months | |
Secondary | Goniometric assessment of active shoulder ROM (range of motion) | Degrees of active range of motion | Baseline | |
Secondary | Goniometric assessment of active shoulder ROM (range of motion) | Degrees of active range of motion | Change from baseline ROM at 10 weeks | |
Secondary | Goniometric assessment of active shoulder ROM (range of motion) | Degrees of active range of motion | Change from baseline ROM at 3 months | |
Secondary | Goniometric assessment of active shoulder ROM (range of motion) | Degrees of active range of motion | Change from baseline ROM at 6 months | |
Secondary | Two point discrimination threshold | Two point discrimination threshold measured at one standardize site on the affected shoulder (5cm distal to the lateral border of the acromion) 33, following an established protocol | Baseline | |
Secondary | Two point discrimination threshold | Two point discrimination threshold measured at one standardize site on the affected shoulder (5cm distal to the lateral border of the acromion) 33, following an established protocol | Change from baseline two point discrimination threshold at 10 weeks | |
Secondary | Two point discrimination threshold | Two point discrimination threshold measured at one standardize site on the affected shoulder (5cm distal to the lateral border of the acromion) 33, following an established protocol | Change from baseline two point discrimination threshold at 3 months | |
Secondary | Two point discrimination threshold | Two point discrimination threshold measured at one standardize site on the affected shoulder (5cm distal to the lateral border of the acromion) 33, following an established protocol | Change from baseline two point discrimination threshold at 6 months | |
Secondary | Laterality judgement accuracy | Laterality judgement accuracy using the NOI Recognise online program (www.noigroup.com) and following and established protocol | Baseline | |
Secondary | Laterality judgement accuracy | Laterality judgement accuracy using the NOI Recognise online program (www.noigroup.com) and following and established protocol | Change from baseline laterality judgement accuracy at 10 weeks | |
Secondary | Laterality judgement accuracy | Laterality judgement accuracy using the NOI Recognise online program (www.noigroup.com) and following and established protocol | Change from baseline laterality judgement accuracy at 3 months | |
Secondary | Laterality judgement accuracy | Laterality judgement accuracy using the NOI Recognise online program (www.noigroup.com) and following and established protocol | Change from baseline laterality judgement accuracy at 6 months | |
Secondary | The Spanish version of the Tampa Scale of Kinesophobia (TSK-11) | The TSK-11 is an 11-item questionnaire assessing fear of movement or fear of (re)injury during movement. It is comprised of 11 items each ranged on a 4-point scale with the end points (1) "totally agree" and (4) "totally disagree" (range: 11-44). Higher scores indicate more fear-avoidance behavior. | Baseline | |
Secondary | The Spanish version of the Tampa Scale of Kinesophobia | The TSK-11 is an 11-item questionnaire assessing fear of movement or fear of (re)injury during movement. It is comprised of 11 items each ranged on a 4-point scale with the end points (1) "totally agree" and (4) "totally disagree" (range: 11-44). Higher scores indicate more fear-avoidance behavior. | Change from baseline Tampa Scale of Kinesophobia at 10 weeks | |
Secondary | The Spanish version of the Tampa Scale of Kinesophobia | The TSK-11 is an 11-item questionnaire assessing fear of movement or fear of (re)injury during movement. It is comprised of 11 items each ranged on a 4-point scale with the end points (1) "totally agree" and (4) "totally disagree" (range: 11-44). Higher scores indicate more fear-avoidance behavior. | Change from baseline Tampa Scale of Kinesophobia at 3 months | |
Secondary | The Spanish version of the Tampa Scale of Kinesophobia | The TSK-11 is an 11-item questionnaire assessing fear of movement or fear of (re)injury during movement. It is comprised of 11 items each ranged on a 4-point scale with the end points (1) "totally agree" and (4) "totally disagree" (range: 11-44). Higher scores indicate more fear-avoidance behavior. | Change from baseline Tampa Scale of Kinesophobia at 6 months | |
Secondary | The Patient Specific Functional Scale | A list of activities and movements is shown to the patients and they are asked to identify the activities that he/she experience difficulty with because of his/her complaints in the shoulder. The patient selects the 3 most important activities and rank them by degree of importance from 0 (no difficulty at all) to 10 (impossible). The total score range from 0 to 30. Higher score indicates higher difficulty in performance on daily activities. | Baseline | |
Secondary | The Patient Specific Functional Scale | A list of activities and movements is shown to the patients and they are asked to identify the activities that he/she experience difficulty with because of his/her complaints in the shoulder. The patient selects the 3 most important activities and rank them by degree of importance from 0 (no difficulty at all) to 10 (impossible). The total score range from 0 to 30. Higher score indicates higher difficulty in performance on daily activities. | Change from baseline Patient Specific Functional Scale at 10 weeks | |
Secondary | The Patient Specific Functional Scale | A list of activities and movements is shown to the patients and they are asked to identify the activities that he/she experience difficulty with because of his/her complaints in the shoulder. The patient selects the 3 most important activities and rank them by degree of importance from 0 (no difficulty at all) to 10 (impossible). The total score range from 0 to 30. Higher score indicates higher difficulty in performance on daily activities. | Change from baseline Patient Specific Functional Scale at 3 months | |
Secondary | The Patient Specific Functional Scale | A list of activities and movements is shown to the patients and they are asked to identify the activities that he/she experience difficulty with because of his/her complaints in the shoulder. The patient selects the 3 most important activities and rank them by degree of importance from 0 (no difficulty at all) to 10 (impossible). The total score range from 0 to 30. Higher score indicates higher difficulty in performance on daily activities. | Change from baseline Patient Specific Functional Scale at 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06181461 -
Gong's Versus Kaltenborn Mobilization on Pain, Range of Motion and Function in Adhesive Capsulitis
|
N/A | |
Recruiting |
NCT03676829 -
Embolization for the Treatment of Pain Secondary to Adhesive Capsulitis
|
Phase 1/Phase 2 | |
Completed |
NCT05897866 -
Sayed Issa's Hybrid Shoulder Arthroscopic-Open Surgical Management (HSSM)
|
N/A | |
Completed |
NCT04747938 -
Frozen Shoulder Treated by Energy Accumulator
|
N/A | |
Recruiting |
NCT05979974 -
High Energy Density Pulse Electromagnetic Field for Patients With Frozen Shoulder
|
N/A | |
Completed |
NCT02169206 -
Clinical Trial on Frozen Shoulder Using Bilateral Shoulder Radiography in Different Position
|
N/A | |
Enrolling by invitation |
NCT03861923 -
Dry Needling for Shoulder Adhesive Capsulitis
|
N/A | |
Completed |
NCT06391567 -
Balance in People With Frozen Shoulder
|
||
Not yet recruiting |
NCT05956171 -
The Effects of Two Different Treatment Protocols on Shoulder Function, Quality of Life, and Ultrasound Parameters in Patients With Frozen Shoulder
|
N/A | |
Recruiting |
NCT04738253 -
Correlation Between Ultrasonography Finding and Shoulder Range of Motion in Stroke Patients
|
||
Not yet recruiting |
NCT06129006 -
Ultrasound Guided Shoulder Anterior Capsular Infiltration Plus Hydrodilatation With Steroid Versus Hyalase in Patients With Frozen Shoulder
|
N/A | |
Completed |
NCT02944526 -
The Effect of 3 Ropivacaine Suprascapular Nerve Blocks in Subacute Adhesive Capsulitis: a Randomized Controlled Trial
|
Phase 4 | |
Recruiting |
NCT02283996 -
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
|
Phase 4 | |
Completed |
NCT02006719 -
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
|
Phase 2 | |
Completed |
NCT01483963 -
AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
|
Phase 2 | |
Completed |
NCT04369144 -
Adding Vertical Correction to Scapular Recognition on Patients With Frozen Shoulder
|
N/A | |
Completed |
NCT03951896 -
Efficacy of Platelet Rich Plasma Injections in Patients With Adhesive Capsulitis of the Shoulder
|
Early Phase 1 | |
Completed |
NCT05993000 -
Assessment of Frozen Shoulder Treatment Using 432 Hertz Frequency Music: A Clinical Trial
|
N/A | |
Completed |
NCT05372497 -
Central Nervous System Focused Therapy in Frozen Shoulder
|
N/A | |
Completed |
NCT04044196 -
Preoperative Psychological Risk Factors for the Retractable Capsulitis of the Shoulder After Shoulder Rotator Cuff Repair Surgery
|